VERNACI, GRAZIA MARIA

VERNACI, GRAZIA MARIA  

Università di Padova  

Risultati 1 - 17 di 17 (tempo di esecuzione: 0.025 secondi).
Titolo Data di pubblicazione Autore(i) Rivista Serie Titolo libro
Use of scalp-cooling device to prevent alopecia for breast cancer patients receiving chemotherapy: a single-Institution prospective study 2017 Giarratano, TGuarneri, VGrosso, DMioranza, EVernaci, GConte, P + ANNALS OF ONCOLOGY - Abstract Book of the 19th National Congress of Medical Oncology 27–29 October 2017, Rome, Italy
Immune characterization of breast cancer metastases: Prognostic implications 2018 Dieci, Maria VittoriaTSVETKOVA, VASSILENAGriguolo, GaiaMiglietta, FedericaCappellesso, RoccoVernaci, GraziaTasca, GiuliaConte, PierfrancoGuarneri, Valentina + BREAST CANCER RESEARCH - -
Patterns of Fertility Preservation and Pregnancy Outcome After Breast Cancer at a Large Comprehensive Cancer Center 2019 Dieci, Maria VittoriaBarbieri, CaterinaGriguolo, GaiaSaccardi, CarloGangemi, MicheleDi Liso, ElisabettaTasca, GiuliaVernaci, GraziaConte, PierfrancoGuarneri, Valentina + JOURNAL OF WOMEN'S HEALTH - -
BMI is an independent prognostic factor for late outcome in patients diagnosed with early breast cancer: A landmark survival analysis 2019 Vernaci G.Dieci M. V.MANFRIN, SILVIAMantiero M.Menichetti A.Griguolo G.Miglietta F.Di Liso E.Conte P.Guarneri V. + THE BREAST - -
Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study 2019 Giarratano T.Frezzini S.Giorgi C. A.Mioranza E.Miglietta F.Griguolo G.Tasca G.Di Liso E.Vernaci G.Menichetti A.Mantiero M.Grosso D.Guarneri V.Dieci M. V. + THE BREAST JOURNAL - -
HER2-Positive Early Breast Cancer 2019 Conte, PierfrancoDieci, Maria VittoriaVernaci, GraziaGuarneri, Valentina - - Oncogenomics: From Basic Research to Precision Medicine
Escalation and de-escalation in HER2 positive early breast cancer 2019 Dieci, Maria VittoriaVernaci, GraziaGuarneri, Valentina CURRENT OPINION IN ONCOLOGY - -
Androgen receptor expression and association with distant disease-free survival in triple negative breast cancer: Analysis of 263 patients treated with standard therapy for stage I-III disease 2019 Dieci M. V.TSVETKOVA, VASSILENAGriguolo G.Miglietta F.MANTIERO, MARACumerlato E.Giorgi C. A.Giarratano T.FAGGIONI, GIULIA MARTINAVernaci G.Menichetti A.MIORANZA, ELEONORAFREZZINI, SIMONAOrvieto E.Guarneri V. + FRONTIERS IN ONCOLOGY - -
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer 2020 Miglietta F.Dieci M. V.Tsvetkova V.Griguolo G.Vernaci G.Menichetti A.Faggioni G.Giarratano T.Mioranza E.Genovesi E.Cumerlato E.Bottosso M.Conte P.Guarneri V. + THE ONCOLOGIST - -
Postsurgical Pyoderma Gangrenosum in a Breast Cancer Patient: A Case Report and Literature Review 2021 Vernaci G. M.DIeci M. V.Orvieto E.Miglietta F.Guarneri V. + CASE REPORTS IN ONCOLOGY - -
Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy 2021 Dieci M. V.Griguolo G.Bottosso M.Tsvetkova V.Giorgi C. A.Vernaci G.Tasca G.Genovesi E.Cumerlato E.Conte P. F.Guarneri V. + NPJ BREAST CANCER - -
ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis 2021 Urso L.Vernaci G.Fassan M.Zulato E.Faggioni G.Menichetti A.Di Liso E.Griguolo G.Conte P.Indraccolo S.Guarneri V.Dieci M. V. + FRONTIERS IN ONCOLOGY - -
Evolution of HER2-low expression from primary to recurrent breast cancer 2021 Miglietta F.Griguolo G.Bottosso M.Giarratano T.Fassan M.Cacciatore M.Genovesi E.De Bartolo D.Vernaci G.Amato O.Conte P. F.Guarneri V.Dieci M. V. + NPJ BREAST CANCER - -
Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer: Results of the Phase II GIADA Trial 2021 Dieci, Maria VittoriaGuarneri, ValentinaTosi, AnnaVernaci, Grazia MariaGriguolo, GaiaUrso, LoredanaRosato, AntonioConte, Pierfranco + CLINICAL CANCER RESEARCH - -
Gene-expression signatures to inform neoadjuvant treatment decision in HR+/HER2− breast cancer: Available evidence and clinical implications 2022 Griguolo G.Bottosso M.Vernaci G.Miglietta F.Dieci M. V.Guarneri V. CANCER TREATMENT REVIEWS - -
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment 2022 Federica MigliettaGaia GriguoloMichele BottossoTommaso GiarratanoMatteo FassanMatilde CacciatoreElisa GenovesiDebora De BartoloGrazia VernaciOttavia AmatoFrancesca PorraPierFranco ConteValentina GuarneriMaria Vittoria Dieci + NPJ BREAST CANCER - -
Efficacia di immunoterapia e chemioterapia come trattamento neoadiuvante nel carcinoma mammario Luminal B-like: risultati dello studio di fase II GIADA. 2022 VERNACI, GRAZIA MARIA - - -